UNSPSC 51373004: Phenazocine

This classification denotes an opioid analgesic and narcotic with the molecular formula C22H27NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J0ND6N0AQC, chemically known as 1,2,3,4,5,6-hexahydro-8-hydroxy-6,11-dimethyl-3-phenethyl-2,6-methano-3-benzazocine but generally known as phenazocine, which bears US NIH Compound Identifier 14707. European Medicines Agency schedules Phenazocine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09752MIG.

UNSPSC 51373004 Phenazocine is a Commodity code that does not map to the recent state and local procurement activity tagged under it. The source contains a single recent opportunity — Seminole County, Florida's IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2026 — that solicits naloxone and drug deactivation systems for community health initiatives, not phenazocine pharmaceutical procurement. Phenazocine is a synthetic opioid with limited legitimate civilian use; the Seminole County bid targets naloxone (an opioid antagonist used in overdose reversal) and drug deactivation equipment, which fall outside the nominal scope of this Commodity code.

The mismatch between code assignment and actual procurement scope suggests either a data entry error in the tagging or a catalog misalignment in the state and local procurement system. No additional recent opportunities under this code are present in the source to establish a pattern of activity or identify issuing-body mix, geographic spread, or representative work. Practitioners evaluating this code should verify the correct UNSPSC designation for opioid-antagonist and drug-destruction-system procurement before pursuing opportunities or updating sourcing intelligence.